regeneron pharmaceuticals market cap 2009

On December 31, 2009, Regeneron Pharmaceuticals (REGN) had a market capitalization of $2B, based on 81.17M shares at a price of $24.18.

DATE CLOSE VOLUME OUTSTANDING MARKET CAP
December 31 2009
$24.18
628,900
81,169,000
$1,962,666,420.00
December 30 2009
$24.74
521,900
81,169,000
$2,008,121,060.00
December 29 2009
$24.43
522,700
81,169,000
$1,982,958,670.00
December 28 2009
$24.40
701,600
81,169,000
$1,980,523,600.00
December 24 2009
$23.20
227,700
81,169,000
$1,883,120,800.00
December 23 2009
$22.97
391,900
81,169,000
$1,864,451,930.00
December 22 2009
$22.52
597,200
81,169,000
$1,827,925,880.00
December 21 2009
$21.95
500,300
81,169,000
$1,781,659,550.00
December 18 2009
$21.41
1,762,300
81,169,000
$1,737,828,290.00
December 17 2009
$20.65
457,900
81,169,000
$1,676,139,850.00
December 16 2009
$20.78
624,800
81,169,000
$1,686,691,820.00
December 15 2009
$20.22
682,600
81,169,000
$1,641,237,180.00
December 14 2009
$19.55
498,600
81,169,000
$1,586,853,950.00
December 11 2009
$18.96
531,100
81,169,000
$1,538,964,240.00
December 10 2009
$18.75
354,900
81,169,000
$1,521,918,750.00
December 09 2009
$18.99
184,700
81,169,000
$1,541,399,310.00
December 08 2009
$18.93
609,200
81,169,000
$1,536,529,170.00
December 07 2009
$19.23
602,400
81,169,000
$1,560,879,870.00
December 04 2009
$19.32
368,700
81,169,000
$1,568,185,080.00
December 03 2009
$19.00
282,300
81,169,000
$1,542,211,000.00
December 02 2009
$19.29
585,800
81,169,000
$1,565,750,010.00
December 01 2009
$18.94
1,211,700
81,169,000
$1,537,340,860.00
November 30 2009
$18.35
521,800
81,169,000
$1,489,451,150.00
November 27 2009
$18.09
199,800
81,169,000
$1,468,347,210.00
November 25 2009
$18.34
353,100
81,169,000
$1,488,639,460.00